BA vs DHR: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
The Boeing Company · Industrials
$222.72
+45.0% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
DHR |
| Current Price |
$222.72 |
$177.17 |
| Fair Value Estimate |
$322.94 |
$192.90 |
| Upside to Fair Value |
+45.0%
|
+8.9%
|
| Market Cap |
$175.6B |
$125.4B |
| Forward P/E |
92.0x
|
34.1x
|
| EV / EBITDA |
29.1x
|
20.8x
|
| Price / Sales |
1.9x
|
5.1x
|
| Price / FCF |
-168.7x
|
23.7x
|
| Revenue Growth YoY |
+14.0%
|
+3.7%
|
| Gross Margin |
4.8%
|
60.7%
|
| Operating Margin |
-5.9%
|
21.0%
|
| Return on Equity |
-8723.1%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
The Boeing Company is a leading global aerospace and defense manufacturer operating in commercial airplanes, defense, space, and global services segments. It benefits from a durable competitive moat as one of only two large commercial aircraft OEMs worldwide, supported by high barriers to entry such as certification complexity and extensive supply chains. Despite strong revenue growth of 14% and …
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
BA |
DHR |
| Zone Low |
$242.20 |
$144.68 |
| Zone High |
$274.50 |
$163.97 |
| In Buy Zone? |
Yes
|
No
|